| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 07/29/2004 | US20040146997 using bacterium grown in the presence of lysine or deregulated for lysine biosynthesis; genetic engineering |
| 07/29/2004 | US20040146923 for treatment of tendinitis and tendon or ligament defects and in related tissue repair, wound healing, and augmenting bone morphogenetic protein (bmp) activity |
| 07/29/2004 | US20040146886 DNA probes, method and kit for identifying antibiotic-resistant strains of bacteria |
| 07/29/2004 | US20040146513 Monoclonal antibodies against human protein Mcm3, process for their production, and their use |
| 07/29/2004 | US20040146506 Antibodies specific for a cell surface molecule mediating cell adhesion and signal transmission, cells secreting such antibodies, and methods of making and using such antibodies |
| 07/29/2004 | DE19935156B4 Verfahren zum Zersetzen von aromatische Gruppen enthaltenden Polyestern, Verfahren zur Denier-Verringerung von Fasern und Mikroorganismen, die eine Aktivität zum Zersetzen derartiger Polyester aufweisen A method for decomposing aromatic group-containing polyesters, process for the denier of fibers and decrease microorganisms having an activity for decomposing such polyesters |
| 07/28/2004 | EP1441033A2 Eukaryotic gene expression cassette based on Herpes simplex virus |
| 07/28/2004 | EP1441029A1 Human cell lines |
| 07/28/2004 | EP1440158A1 Method for the production of (r)- and (s)-8-chloro-6-hydroxy-octanic acid alkyl esters by enzymatic reduction |
| 07/28/2004 | EP1440144A2 Blakeslea trispora producing high yield of lycopene in a suitable medium in the absence of an exogenous carotenogenesis inhibitor |
| 07/28/2004 | EP1440087A2 Mycobacterial genes down-regulated during latency |
| 07/28/2004 | EP1439863A2 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism |
| 07/28/2004 | EP1261697B1 Cold-active beta galactosidase, the process for its preparation and the use thereof |
| 07/28/2004 | EP1121331B1 Microbiological method for eliminating a nitroaromatic compound |
| 07/28/2004 | EP1028739B1 Use of protein h as cytostatic agent |
| 07/28/2004 | EP0912741B1 T-cell selective interleukin-4 agonists |
| 07/28/2004 | EP0728214B1 Stable cell lines capable of expressing the adeno-associated virus replication gene |
| 07/28/2004 | EP0584214B1 Gene manipulation and expression using genomic elements |
| 07/28/2004 | EP0452484B2 Production of proteins using homologous recombination |
| 07/28/2004 | CN1516737A Process for preparation of gallic acid by co-culture |
| 07/28/2004 | CN1515674A Biological pure culture for Nocardia |
| 07/28/2004 | CN1515673A Preparation method of antipode of (1R, 4S)-or (1S, 4R)-1-amino-4-(methylol)-2-cyclopentene derivative |
| 07/28/2004 | CN1515672A Human chemotactic factor beta-8, chemotactic factor beta-1 and macrophage inflammatory protein-4 |
| 07/28/2004 | CN1515667A Livstock mucosal competitive exclusion culture for reducing enteropathogenic bacteria |
| 07/28/2004 | CN1515591A Growth hormone and serum albumni recombinant fusion protein |
| 07/28/2004 | CN1159584C Method and medicine box of testing anti-hepatitis C virus antibody |
| 07/28/2004 | CN1159450C Low oxygen affinity mutant hemoglobin |
| 07/28/2004 | CN1159444C Mutated penicilling acylase genes |
| 07/28/2004 | CN1159442C Novel stranis of bacillus subtilis group for food fermentation |
| 07/28/2004 | CN1159436C Ensyme with aminopeptidase activity |
| 07/27/2004 | US6768001 Xylanase from trichoderma reesei, method for production thereof, and methods employing this enzyme |
| 07/22/2004 | WO2003082184A3 Truncated lysostaphin molecule with enhanced staphylolytic activity |
| 07/22/2004 | US20040143867 High level production of p-hydroxybenzoic acid in green plants |
| 07/22/2004 | US20040143087 prepared by culturing a microorganism in a medium containing a 3-cyclohexylpropionic acid; binder resin is biodegradable; facilitates deinking to accelerates recycling of used copying paper; toner for developing an electrostatic charge image. |
| 07/22/2004 | US20040142990 Concentrating epothilone in culture; complexing; antiproliferative agents |
| 07/22/2004 | US20040142478 Expression vector comprising saccharomyces regulatory sequences for controlling heterologous and homologous gene expression; genetic engineering protein translation |
| 07/22/2004 | US20040142453 Mycobacterial proteins, microorganisms producing them and their use for vaccines and for the detection of tuberculosis |
| 07/22/2004 | US20040142447 Microbiological method for producing amides |
| 07/22/2004 | US20040142435 Using genetically engineered methylophilus comprising enhanced 6-phosphogluconate dehydratase and/or 2-keto-3-dexoy-6-phosphogluconate aldolase activities to prepare lysine, leucine, isoleucine and valine; bioreactors |
| 07/22/2004 | US20040142432 Preparing single chain antibodies comprised of camelid subunits for treating and preventing inflammation, allergies, cancer, infections, transplant rejection, autoimmune and muscular disorders |
| 07/22/2004 | US20040142424 Transforming cells with genetically engineered phytic acid degrading enzyme for use in improving digestability and nutritional quality of animal feeds |
| 07/22/2004 | US20040142417 Receptor proteins |
| 07/22/2004 | US20040142348 solid phase synthesis; for diagnosis/treatment/prophyaxis; animal models; genetic engineering |
| 07/22/2004 | US20040142319 provide a hish speed/user-friendly alternative to haemagglutination-inhibition, fluorescent antibody and enzyme immunoassay, and reverse transcriptase polymerase chain reaction (RT-PCR); solid phase synthesis |
| 07/22/2004 | US20040141997 Methods for treating or preventing infections from coagulase-negative staphylococci |
| 07/22/2004 | US20040141991 novel prostatic acid phosphatase and corresponding coding region derived from mouse; immunizing a subject with a xenogeneic polypeptide antigen, either alone, as part of a viral antigen construct, or as part of a pulsed dendritic cell preparation. |
| 07/22/2004 | US20040141982 Use of genetically engineered antibodies to treat multiple myeloma |
| 07/21/2004 | EP1439230A2 Human transmembrane protein TMP-2 gene |
| 07/21/2004 | EP1439190A1 Growth differentiation factor-5 |
| 07/21/2004 | EP1438400A1 Multi-chain eukaryotic display vectors and uses thereof |
| 07/21/2004 | EP1438377A1 Cholesterol lowering structured lipids with omega 3 pufa |
| 07/21/2004 | EP1200110A4 In vivo induction for enhanced function of isolated hepatocytes |
| 07/21/2004 | EP0959904B1 Hybrid compositions for intracellular targeting |
| 07/21/2004 | EP0815224B1 Receptor activation by gas6 |
| 07/21/2004 | EP0767176B1 Novel glyceroglycophospholipid, antibody there against, and method of detecting mycoplasma |
| 07/21/2004 | CN1513997A Method of detecting 5'-methioadenosine phosphorylase defect type mammarian cell |
| 07/21/2004 | CN1513383A Dried lactic acid bacteria, and its prodn. method |
| 07/21/2004 | CN1158383C Functional composition. |
| 07/20/2004 | US6764843 Method of cloning and expression of BsmBI restriction endonuclease and BsmBI methylase in E. coli and purification of BsmBI endonuclease |
| 07/20/2004 | US6764841 Grenerating glucose-1-phosphate in culture; obtain corneybacterium, culture in medium containng saccharide and phosphoric acid, recover accmulated glucose-1-phosphate |
| 07/20/2004 | US6764827 For detection and measurement of serine proteases found in granulocytes |
| 07/20/2004 | US6764685 Chimeric viruses; cdna or rna used to express heterologous gene products in host cell systems and/or to rescue negative strand rna recombinant viruses |
| 07/20/2004 | CA2284858C Probes for the diagnosis of infections caused by klebsiella pneumoniae |
| 07/20/2004 | CA2096159C Peptides that induce antibodies which neutralize genetically divergent hiv-1 isolates |
| 07/15/2004 | WO2004046346A3 Self-containing lactobacillus strain |
| 07/15/2004 | WO2003083056A3 Secretion of proteins with multiple disulfide bonds in bacteria and uses thereof |
| 07/15/2004 | WO2002101074A3 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines |
| 07/15/2004 | US20040139501 Expression vector coding linalool synthase (LIS)promoter for use as tool in controlling tissue directed heterologous gene expression in plants; tissue engineering |
| 07/15/2004 | US20040138443 Comprises nucleotide sequences coding interleukin receptor ligand for enhancing stimulation and regulation of host response to injury and infection |
| 07/15/2004 | US20040137620 Compositions corresponding to a calcium transporter and methods of making and using same |
| 07/15/2004 | US20040137603 Circuit arrangement for injecting nucleic acids and other biologically active molecules into the nucleus of higher eucaryontic cells using electrical current |
| 07/15/2004 | US20040137600 Propagating nematode parasitic bacteria for use as tools in generating disease resistant crops; biological pest control |
| 07/15/2004 | US20040137596 Method for purifying an enzyme, a purified enzyme produced thereby, and use of this enzyme |
| 07/15/2004 | US20040137586 Biological systems for manufacture of polyhydroxyalkanoate polymers containing 4-hydroxyacids |
| 07/15/2004 | US20040137584 Biotin biosynthetic genes |
| 07/15/2004 | US20040137570 Immunoglobulin 2 |
| 07/15/2004 | US20040137556 Yeast strains autonomously producing steroids |
| 07/15/2004 | US20040137555 for producing androst-4-ene-3,17-dione (AD) and androsta-1,4-diene-3,17-dione (ADD) by fermentation; for mass production |
| 07/15/2004 | US20040137421 Deposition of the protein in the follicular dendritic cell of a non-human animal and detection by histology, electrophoresis or binding assay |
| 07/15/2004 | US20040137015 equine influenza virus genome segment confers at least one identifying phenotype of a cold-adapted equine influenza virus on the reassortant virus, and genetically-engineered equine influenza viruses, produced through reverse genetics |
| 07/15/2004 | US20040136995 antibody, or fragment thereof, that specifically binds an ACT-4-h-1 receptor; has different binding specificity than a monoclonal antibody generated by hybridoma HBL106 |
| 07/15/2004 | DE10352801A1 Verfahren zur Herstellung von L-Aminosäuren unter Verwendung von Methanol-Assimilierenden Bakterien A method for producing L-amino acids using methanol-assimilating bacteria |
| 07/14/2004 | EP1437411A1 Glucose dehydrogenase |
| 07/14/2004 | EP1183265A4 Novel fabh enzyme, compositions capable of binding to said enzyme and methods of use thereof |
| 07/14/2004 | EP0827534B1 Detergents comprising cellulases |
| 07/14/2004 | EP0824588B1 Il-6 activity inhibitor |
| 07/14/2004 | EP0754227B1 Chimeric complement inhibitor proteins |
| 07/14/2004 | CN1513056A Production of bioarailable folic acid |
| 07/14/2004 | CN1157484C Assay for detecting phospho-N-acetylmuramyl-pentapentide translocase activity |
| 07/14/2004 | CN1157480C Butyrobetaine/crotonbetaine-L-carnitine metabolic gene and its use in producing L-carnition by microbial method |
| 07/14/2004 | CN1157406C Novel, ATP-sensitive potassium-channel proteins and genes for the same |
| 07/13/2004 | US6762295 For the treatment or prevention of gastroduodenal disease associated heliobacter infections |
| 07/13/2004 | US6762051 Methods of inhibiting helicobacter pylori |
| 07/13/2004 | US6762037 Process for producing coenzyme Q10 |
| 07/13/2004 | US6761893 Modified vaccinia ankara virus variant |
| 07/13/2004 | US6761885 Used for treating and/or preventing urogenital infections |
| 07/13/2004 | US6761876 Methods for introducing helterologous cells into fish |
| 07/13/2004 | CA2052413C Nucleotides sequences useful as type-specific probes, pcr primers and lcr probes for the amplifications and detection of human papilloma virus, and related kits and methods |
| 07/08/2004 | WO2004057013A1 PROCESS FOR PRODUCING 7α-HYDROXYPREGN-4-EN-3-ONE-20-CARBALDEHYDE |
| 07/08/2004 | WO2004024909A3 Recombinant colstridium neurotoxin fragments |